Sterling Investment Advisors, Ltd. - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 77 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
Sterling Investment Advisors, Ltd. ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$14,000
-48.1%
3,1500.0%0.01%
-37.5%
Q1 2022$27,000
-40.0%
3,1500.0%0.01%
-38.5%
Q4 2021$45,000
-34.8%
3,1500.0%0.01%
-38.1%
Q3 2021$69,000
+64.3%
3,1500.0%0.02%
+75.0%
Q2 2021$42,000
+31.2%
3,1500.0%0.01%
+20.0%
Q1 2021$32,000
+146.2%
3,1500.0%0.01%
+150.0%
Q4 2020$13,000
+62.5%
3,1500.0%0.00%
+33.3%
Q3 2020$8,000
-27.3%
3,1500.0%0.00%
-40.0%
Q2 2020$11,000
+22.2%
3,1500.0%0.01%0.0%
Q1 2020$9,000
-43.8%
3,1500.0%0.01%
-28.6%
Q4 2019$16,000
+60.0%
3,1500.0%0.01%
+40.0%
Q3 2019$10,000
-9.1%
3,1500.0%0.01%
-16.7%
Q2 2019$11,0000.0%3,1500.0%0.01%0.0%
Q1 2019$11,000
+22.2%
3,1500.0%0.01%
+20.0%
Q4 2018$9,000
-40.0%
3,1500.0%0.01%
-37.5%
Q3 2018$15,000
-34.8%
3,1500.0%0.01%
-42.9%
Q2 2018$23,000
+9.5%
3,1500.0%0.01%
+7.7%
Q1 2018$21,000
-25.0%
3,1500.0%0.01%
-23.5%
Q4 2017$28,000
-9.7%
3,1500.0%0.02%
-19.0%
Q3 2017$31,000
+29.2%
3,1500.0%0.02%
+31.2%
Q2 2017$24,000
+26.3%
3,1500.0%0.02%
+14.3%
Q1 2017$19,0000.0%3,1500.0%0.01%
-6.7%
Q4 2016$19,0003,1500.02%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Acrospire Investment Management LLC 8,355$61,0000.04%
TOCQUEVILLE ASSET MANAGEMENT L.P. 70,000$508,0000.01%
Financial Architects, Inc 2,000$15,0000.00%
FineMark National Bank & Trust 3,473$25,0000.00%
JFS WEALTH ADVISORS, LLC 1,000$7,0000.00%
Penserra Capital Management LLC 2,540$18,0000.00%
Tower Research Capital LLC (TRC) 1,284$10,0000.00%
SIMPLEX TRADING, LLC 2,673$19,0000.00%
Plante Moran Financial Advisors, LLC 300$2,0000.00%
Cutler Group LLC / CA 2,404$17,0000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders